|
CDK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63763999999622E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.23859999999299E-05 |
| Normal-vs-Stage2 |
3.534100E-02 |
| Normal-vs-Stage3 |
1.440140E-03 |
| Normal-vs-Stage4 |
3.806900E-04 |
| Stage1-vs-Stage2 |
2.382200E-01 |
| Stage1-vs-Stage3 |
5.342600E-01 |
| Stage1-vs-Stage4 |
3.275000E-01 |
| Stage2-vs-Stage3 |
5.412000E-01 |
| Stage2-vs-Stage4 |
1.197770E-01 |
| Stage3-vs-Stage4 |
2.089600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.00929999999833E-05 |
| Normal-vs-AfricanAmerican |
3.600200E-02 |
| Normal-vs-Asian |
1.287830E-02 |
| Caucasian-vs-AfricanAmerican |
4.087200E-01 |
| Caucasian-vs-Asian |
4.280200E-01 |
| AfricanAmerican-vs-Asian |
3.424800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.77940000000354E-05 |
| Normal-vs-Female |
8.13660000000826E-05 |
| Male-vs-Female |
8.035000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.553500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.56523999998992E-05 |
| Normal-vs-Age(61-80Yrs) |
2.824000E-04 |
| Normal-vs-Age(81-100Yrs) |
2.437800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.361600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.543800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.603760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.920200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.711000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.930000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.582450E-03 |
| Normal-vs-Grade 2 |
1.82329999998121E-06 |
| Normal-vs-Grade 3 |
2.378900E-03 |
| Normal-vs-Grade 4 |
1.518020E-03 |
| Grade 1-vs-Grade 2 |
3.826600E-01 |
| Grade 1-vs-Grade 3 |
1.091430E-01 |
| Grade 1-vs-Grade 4 |
6.381600E-01 |
| Grade 2-vs-Grade 3 |
3.133600E-02 |
| Grade 2-vs-Grade 4 |
6.147000E-01 |
| Grade 3-vs-Grade 4 |
1.374810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.6455999999967E-05 |
| Normal-vs-ccB subtype |
1.87268999999324E-05 |
| ccA subtype-vs-ccB subtype |
1.625230E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.4285999999929E-05 |
| Normal-vs-N1 |
2.293800E-02 |
| N0-vs-N1 |
2.114400E-01 |
|
|
